DynPort Vaccine Company LLC, A GDIT Company

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, DynPort Vaccine Company LLC, A GDIT Company sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials none currently recruiting 7 completed early-phase tilt upper quartile by trial count

DynPort Vaccine Company LLC, A GDIT Company: 7 sponsored US clinical trials, none currently recruiting.

DynPort Vaccine Company LLC, A GDIT Company sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Preventive Therapy, with 1 trials.

Upper-quartile sponsor footprint

DynPort Vaccine Company LLC, A GDIT Company sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

7 total, page 1 of 1

COMPLETED Phase 2

Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant

NCT01122784
COMPLETED Phase 2

Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

NCT00764634
COMPLETED Phase 2

Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers

NCT00332956
COMPLETED Phase 1

Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V

NCT00097396
COMPLETED Phase 1

Study to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy Adults

NCT00098098
COMPLETED Phase 1

A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults

NCT00057525
COMPLETED Phase 1

Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®

NCT00042094

Phase Distribution

PhaseTrial count
Phase 1 4
Phase 2 3

Therapeutic Areas

Preventive Therapy 1
Pneumonic Plague 1
Plague Vaccine 1

How the DynPort Vaccine Company LLC, A GDIT Company early-phase archive is shaped

7 indexed studies, none listed as recruiting (0% open); 7 completed (100%).

Phase mix: 0 late (III/IV) vs 7 early (I/II) (early-phase heavy).

Top condition: Preventive Therapy (1 trial), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

DynPort Vaccine Company LLC, A GDIT Company: archived-pipeline peers nationwide

Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

DynPort Vaccine Company LLC, A GDIT Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share DynPort Vaccine Company LLC, A GDIT Company3M4Life Research89bioAbbott Diagnostics Division10xBio22nd Century Group23andMe3-C Institute for Social Development
DynPort Vaccine Company LLC, A GDIT Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

DynPort Vaccine Company LLC, A GDIT Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this DynPort Vaccine Company LLC, A GDIT Company page

7 registered trials is a research-attention snapshot, not an endorsement of DynPort Vaccine Company LLC, A GDIT Company or any single study.

  • None of DynPort Vaccine Company LLC, A GDIT Company's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Preventive Therapy is the condition DynPort Vaccine Company LLC, A GDIT Company studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Preventive Therapy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. DynPort Vaccine Company LLC, A GDIT Company pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.